Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6793928 | 0.71 | GABRA1 (0.35) | GABRA1GABRB2 | |
| SCHEMBL17200648 | 0.69 | GABRA1 (0.35) | GABRA1GABRB2 | |
| SCHEMBL6729917 | 0.69 | KDM4E (0.38) | EGFRKDR | |
| SCHEMBL17649223 | 0.66 | GABRA1 (0.35) | GABRA1GABRB2 | |
| SCHEMBL11555693 | 0.66 | GABRA1 (0.36) | GABRA1GABRB2 | |
| SCHEMBL25573712 | 0.66 | GABRA1 (0.36) | GABRA1GABRB2 | |
| SCHEMBL17650908 | 0.65 | GABRA1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL17648937 | 0.65 | GABRA1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL4113652 | 0.63 | AHR (0.55) | — | |
| SCHEMBL20744683 | 0.63 | GABRA1 (0.32) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040018941-A1 | Fused-benzene derivatives of thiouracil, herbicidal and desiccant compositions contaning them | ISHIHARA SANGYO KAISHA, LTD. | 2004-01-29 | — | — | US | disclosed |
| WO-2004008859-A1 | FUSED-BENZENE DERIVATIVES OF THIOURACIL, HERBICIDAL AND DESICCANT COMPOSITIONS CONTANING THEM | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2004-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040018941-A1 | Fused-benzene derivatives of thiouracil, herbicidal and desiccant compositions contaning them | DDT, DPYD, TST | GABRA1 473/4885GABRB2 356/4885EGFR 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.